TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INNOVATIVE TECHNOLOGY CLINICAL RESULTS IT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

INNOVATIVE TECHNOLOGY CLINICAL RESULTS IT

ST13

US500000097166279

Class

3

Filing

97166279

Registration

7280184

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

01/24/2024

Classification

Registered

Trademark type

Combined

Nice classes

3

Filing date

12/10/2021

Registration date

01/16/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/16/2024

Last transaction

01/16/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2023-07-00

First use in commerce

2023-07-00

Drawing code

3

Owner type

03

Owner location

NEW YORK, NY

Examiner

FOSTER, SHATONI A

Law office

N30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized script term "IT" surrounded by a circle; that inner circle is ringed with the text "INNOVATIVE TECHNOLOGY CLINICAL RESULTS," with a dot before "INNOVATIVE" and after "TECHNOLOGY." This text is also enclosed by a circle.

Holders and representatives

Holders

L'OREAL USA S/D, INC.
L'Oreal USA Creative, Inc.

Representatives

Lisa M. Gigliotti L'OREAL USA CREATIVE, INC.

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated skin care preparations

Publications

History of USPTO decisions and trademark events.

22 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/24/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/16/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/16/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/13/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/12/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/12/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/11/2023

IUAF

USE AMENDMENT FILED

12/04/2023

EISU

TEAS STATEMENT OF USE RECEIVED

12/04/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/12/2023

EX1G

SOU EXTENSION 1 GRANTED

04/10/2023

EXT1

SOU EXTENSION 1 FILED

04/10/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/10/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/20/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/25/2022

PUBO

PUBLISHED FOR OPPOSITION

10/25/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/22/2022

DOCK

ASSIGNED TO EXAMINER

09/16/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/16/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/15/2021

NWAP

NEW APPLICATION ENTERED

12/14/2021

Continuous trademark protection

Get notified about every new filing that threatens INNOVATIVE TECHNOLOGY CLINICAL RESULTS IT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.